Hydatid liver cyst: an 11-year experience of treatment with percutaneous aspiration and ethanol injection.

2001 ◽  
Vol 20 (7) ◽  
pp. 729-738 ◽  
Author(s):  
A Giorgio ◽  
L Tarantino ◽  
G de Stefano ◽  
G Francica ◽  
N Mariniello ◽  
...  
Keyword(s):  
Liver Cyst ◽  
Percutaneous Aspiration ◽  
Ethanol Injection

Laparoscopic aspiration and excision versus double percutaneous aspiration, ethanol injection and re-aspiration for treatment of viable univesicular hydatid liver cysts

2011 ◽  
Vol 8 (1) ◽  
pp. 9-18
Author(s):  
Samy Saad ◽  
Alaa El-Ashry ◽  
A Meccawy ◽  
Osama Murshed ◽  
Khaled A Ahmad ◽  
...  
Keyword(s):  
Percutaneous Aspiration ◽  
Ethanol Injection ◽  
Liver Cysts

scholarly journals Treatment of a giant hepatic echinococcal cyst with percutaneous drainage and in vivo assessment of the protoscolicidal effect of praziquantel

2021 ◽  
Author(s):  
Joachim Richter ◽  
Andreas Karl Lindner ◽  
Dominik Geisel ◽  
Giovanni Federico Torsello ◽  
Gabriela Equihua Martinez ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Percutaneous Drainage ◽  
Liver Cyst ◽  
Percutaneous Aspiration ◽  
Liver Cysts ◽  
Secondary Spread ◽  
Echinococcal Cyst ◽  
Cyst Cavity ◽  
In Vivo Assessment

AbstractTherapy choices for cystic echinococcisis (CE) are stage-specific: surgical, minimally invasive, medical or observation without intervention. PAIR (percutaneous aspiration, instillation of a scolicide, and re-aspiration) has been considered the treatment of choice for uncomplicated echinococcal liver cysts. However, PAIR carries the risk of toxic cholangitis or hypernatremia and that the cyst frequently refills with bile after withdrawing the catheter. We treated a patient with a giant CE 1 liver cyst with puncture drainage (PD) under albendazole coverage. Drainage enabled us to monitor the morphology of protoscolices under praziquantel (PZQ) co-medication. Protoscolices degenerated within 5 days of PZQ 50 mg/kg/d. The cyst cavity solidified with no evidence of reactivation or secondary spread. Percutaneous treatments can replace surgery in a significant number or cases with hepatic CE. PD allows to assess microscopically the viability of protoscolices under co-medication with PZQ–albendazole and to avoid the instillation of topical scolicides.

Double percutaneous aspiration and alcohal injection (D-PAI): A safe and effective therapy for hydatid liver cyst (HLC)

1991 ◽  
Vol 13 ◽  
pp. S32
Author(s):  
A. Giorgio ◽  
L. Tarantino ◽  
G. Francica ◽  
N. Mariniello ◽  
G. Pierri
Keyword(s):  
Liver Cyst ◽  
Effective Therapy ◽  
Percutaneous Aspiration

scholarly journals An Elderly Case of Giant Infected Liver Cyst That Decreased Dramatically without Percutaneous Aspiration.

1999 ◽  
Vol 36 (5) ◽  
pp. 369-372
Author(s):  
Hiroshi Yamaguchi ◽  
Kenzo Oba ◽  
Makoto Yano ◽  
Kyoji Okazaki ◽  
Yoshimasa Igari ◽  
...  
Keyword(s):  
Liver Cyst ◽  
Percutaneous Aspiration ◽  
Infected Liver

scholarly journals Treatment of Large Liver Cyst Evaluated with CA19-9 in the Cystic Fluid

HPB Surgery ◽  
1996 ◽  
Vol 9 (3) ◽  
pp. 179-182 ◽  
Author(s):  
Yasuharu Ikeda ◽  
Katsumi Kawasaki ◽  
Tetsuo Ikeda ◽  
Hiroyuki Uchida ◽  
Kazumasa Morinaga
Keyword(s):  
Liver Cyst ◽  
Absolute Ethanol ◽  
Middle Aged ◽  
Cystic Fluid ◽  
Ethanol Injection ◽  
Liver Cysts ◽  
Aged Woman ◽  
Middle Aged Woman

A middle-aged woman was admitted with a diagnosis of liver cysts. The patient was symptomatic and was treated by injecting absolute ethanol into the largest cyst every week, but the secretion from the cyst persisted. The patient was then treated by absolute ethanol injection every day with good results. CA 19-9 was measured in the cystic fluid. The secretion was related to CA 19-9 activity.Thus, for patients with symptoms from a liver cyst, the injection of ethanol every day can be effective. CA19-9 level in the contents of the liver cyst was an important factor in assessing the effect of ethanol injection on the liver cyst.

Intraoperative abdominal ultrasonography-guided large volume ethanol injection for hepatocellular carcinoma

2001 ◽  
Vol 120 (5) ◽  
pp. A482-A482
Author(s):  
R MONDRAGONSANCHEZ ◽  
A GARDUOLOPEZ ◽  
H MURRIETA ◽  
M FRIASMENDIVIL ◽  
R ESPEJO ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Large Volume ◽  
Abdominal Ultrasonography ◽  
Ethanol Injection

Nonsurgical Therapies for Hepatocellular and Cholangiocellular Carcinoma

Swiss Surgery ◽  
1999 ◽  
Vol 5 (3) ◽  
pp. 116-121 ◽  
Author(s):  
Schmassmann
Keyword(s):  
Current Trend ◽  
Percutaneous Ethanol Injection ◽  
Cholangiocellular Carcinoma ◽  
Multidisciplinary Therapy ◽  
Term Survival ◽  
Ethanol Injection ◽  
First Choice ◽  
Tumor Stages ◽  
Choice Of Treatment ◽  
Advanced Stages

Surgical resection is the first choice of treatment for patients with hepatocellular (HCC) and cholangiocellular carcinomas. Prolongation of survival is, however, the only realistic goal for most patients, which can be often achieved by nonsurgical therapies. Inoperable patients with large or multiple HCCs are usually treated with transarterial chemoembolization (TACE) with lipiodol in combination with a chemotherapeutic drug and gelfoam. Three-year survival depends on the stage of the disease and is about 20%. Patients with earlier tumor stages (one or two tumor nodules less than 3cm in size) are suitable for treatment with percutaneous ethanol injection (PEI) alone or in combination with TACE. Several studies have shown that in these early stages, the 3-year survival rate is approximately 55%-70% in the actively treated patients which is significantly higher than in untreated patients. In advanced stages of the disease, TACE and PEI have no effect on survival and should not be performed. Some of these patients have been successfully treated with octreotide. Patients with inoperable cholangiocellular carcinoma are treated by endoscopic or percutaneous stent placement. If stenting does not achieve adequate biliary drainage, multidisciplinary therapy including internal / external radiotherapy or photodynamic therapy should be considered in patients with potential long-term survival. In conclusion, nonresectional therapies play an essential role in the therapy of inoperable hepato- and cholangiocellular carcinomas as they lead to satisfactory survival. Multidisciplinary therapy appears to be the current trend of management.

Sign in / Sign up

Export Citation Format

Share Document